ANN ARBOR – MichBio, the association for

Michigan’s biosciences industry, Monday announced the names of the winning

applicants for its Emerging Biosciences Showcase on Nov. 18, the first day

of its statewide Expo. The purpose of the Showcase is to introduce venture

capital firms from around the country to biosciences start-ups emerging in

Michigan. The event provides selected companies with an opportunity to

introduce their technologies to an audience of investors, technology

experts, and other entrepreneurs.

The Expo is the largest annual gathering of biosciences professionals

in the state and will be held Nov. 18-19 at the Rock Financial ShowPlace in

Novi. This is the first time the Emerging Biosciences Showcase has been

part of the Expo. The inaugural showcase was held last May in advance of

the Michigan Growth Capital Symposium in Ann Arbor. Twelve companies

presented at that event.

“We’re excited to have the Emerging Biosciences Showcase as part of the

Expo, which is a natural home for it,” said Stephen Rapundalo, Ph.D.,

MichBio president and CEO. “We have expanded the format to allow a greater

number of companies to introduce their new bioscience technologies and

commercialization opportunities to the venture capital and angel investor

community.”

The program, which runs from 1-5:00 p.m., will begin with a keynote

address by Shelley B. Thunen, CFO of TherOx, Inc. in Irvine CA. Thunen has

held key management positions in a number of start-up companies, including

serving as CFO of IntraLase Corp. Following her comments, the program will

continue with nine-minute company presentations. Presenting companies

include:

AI Medical Devices, Inc. – Medical devices emphasizing improved intubation

procedures.

Armune BioScience, Inc. – High-value, protein signature-based

diagnostic/prognostic tests for certain cancers.

Aursos, Inc. – Drugs treatment for bone loss.

Biotectix, LLC. – Developing bioactive, electronically-conductive

polymers/coatings for implantable devices.

CanCure Laboratories, LLC, – Developing small molecule drug to prevent

unintended weight loss and protect bone marrow in cancer patients.

HistoSonics, LLC. – Non-invasive surgical modality using ultrasound energy

to liquefy target tissue.

Jade Biomed. – Needle-free acupuncture point evaluation and stimulation

system.

NamesforLife, LLC. – Innovative products to extract meaning from

information based on rapidly changing, dynamic terminologies.

Nephrion, Inc. – Medical devices using commercially available dialyzer

cartridges in specific configurations with a widely used regional

anticoagulant to treat large, unmet medical needs.

NeuMedicine International, Inc. – Telemedicine software and services for

low-cost radiology imagery storage.

Next Generation Therapeutics, Inc. – Innovative nanotechnology products

for treatment of cancer that significantly reduce the side effects of

chemotherapeutics.

OcuSciences, Inc. – Proprietary ocular imaging technique for early disease

screening.

Pharmaceutical Enhancement Technologies – Exploring enhancement platforms for modification to tried-and-true pharmaceuticals to produce improved

efficacy/safety while extending patent protection.

SciTech Development – Solving a delivery problem for well characterized

and promising anti-cancer agent, fenretinide.

Wellness Indicators – Make and market tests for biomarkers of human

wellness and disease risk.

The showcase is followed by the MichBio Expo’s Opening Reception, where

many of the presenting companies will have tabletop displays in the hall to

provide time for one-on-one conversations. Those wishing to attend the

Emerging Biosciences Showcase should click on MichBio.Org/Expo

a>>